Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape

Science

Volumn 274, Issue 5291, 1996, Pages 1363-1366

  Hahne, M ^a   Rimoldi, D ^a   Schroter M ^a   Romero, P ^a   Schreier, M ^a   French, L E ^b   Schneider, P ^a   Bornand, T ^a   Fontana, A ^c   Lienard, D ^d   Cerottini, J C ^a   Tschopp, J ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ETIOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; HUMANS; LIGANDS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR ESCAPE;

ANIMALIA;

EID: 10544232277     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.274.5291.1363     Document Type: Article

References (41)

1. S. Nagatae and P. Golstein, Science 267, 1449 (1996)
2. D. Kagi et al., ibid 265, 528 (1994).
3. B. Lowin, M. Hanne, G. Mattmann, J. Tschopp, Nature 370, 680 (1994)
4. M. Y. Braun, B. Lowit. L. French, H. Acha-Orbea, J. Tschopp, J. Exp Med 183, 657 (1996).
5. J H. fessiol B. Riss C. Weaver, R. Wang, Proc. Natl. Acad Sci U.S.A. 90, 4409 (1993).
6. G. G. Singer and A. R. Abbas, Immunity 1, 365 (1994).
7. K. M. Mohler et al., Nature 370, 218(1994).
8. G. M. MoGeehan et al., ibid., p. 558.
9. M. Tanaka, T. Suda, T. Takanashl, S. Nagata, EMBO J. 14, 1129 (1999).
10. S. M. Masseni, B. Matins, C. Baumler, P. H. Krammer: Eur. J. immunol, 25, 2303 (1995).
11. N. Kayagaki et al., J. Exp. Med. 182, 1777 (1995).
12. M. Hahne et al., in preparation.
13. T. Suda, T. Taka P. Golstein, S. Nagata, Cell 75, 1169 (1993)
14. L.E. French et al Coll Biol., 335 (1996).
15. O. Beilgrau et al., Nature 377, 530 (1995).
16. T. S. Griffin. T. Brunner, S. M. Fletcher, D. R. Green, T. A. Ferguson, Science 270, 1189 (1995).
17. G. Klein and T. Boon. Curr. Opin. Immunol. 5, 687 (1993).
18. S. A. Rosenberg et al., N. Engl. J. Med. 319, 1676 (1988).
19. M. Hahne et al., data not shown.
20. S. Hahn et al., Eur. J. Immunol. 25, 2679 (1995).
21. Y. Gavrieu, Y. Sherman, S.A. Ben-Sasson, J. Cell Biol. 119, 493 (1992).
22. I. J. Fidler, Nature New Biol. 242, 148 (1973).
23. L. M. Muul, P. J. Spiess, E. P. Director, S. A. Rosenberg, J. Immunol. 138, 989 (1987).
24. M. Herin et al., Int. J. Cancer 39, 390 (1987).
25. T. Boon, J. C. Cerottini, B. Van den Eynde, P. van der Bruggen. A. Van Pel, Annu. Rev. Immunol. 12, 337 (1994).
26. A. Van Pel et al., Immunol. Rev. 145, 229 (1995).
27. B. Mukherji and N. G. Chakraborty, Curr. Opin. OnCol. 7, 175 (1995).
28. D. Huber, J. Philipp, A. Fontana, J. Immunol. 148, 277 (1992).
29. S. Ferrone and F. M. Marincola, Immunol. Today 16, 487 (1995).
30. K. Zier, B. Gansbacher, S. Savadori, ibid. 17, 39 (1996).
31. H. T. Lau, M. Yu, A. Fontana, C. J. Stoeckert, Science 273, 109 (1996).
32. 6 melanoma cells were separated by SDS-PAGE (10%) under nonreducing conditions and immunoblotted (ECL system, Amersham) using the affinity-purified rabbit anti-FasL antibody PE62 (33).
33. M. Hahne et al., Int. Immunol. 7, 1381 (1995).
34. 5 labeled cells in a total volume of 200 μ1.
35. 2 and 0.1% azide. Supernatants (1:1 dilution) of the monoclonal antibody (mAb) to FasL, A11 (33) (Alexis Corp., San Diego, CA) was added to the section for 1 hour, and after rinsing in PBS, peroxidase-conjugated goat antibody to rat Ig (TAGO, Burlingame, CA) was added for 0.5 hour. After rinsing, antibody location was revealed by the AEC chromogen. For the detection of melanoma cells, a mouse mAb to MAGE-1, detecting a subpopulation of melanoma cells (40), was used (20 μg/ml), and detected with a biotinylated goat anti-mouse Ig and avidin-peroxidase-conjugate (TAGO, Burlingame, CA). Fas antigen was detected with a mouse mAb to human Fas (10 μg/ml). In the negative control, the FasL antibody was replaced with rat Ig. The mAb to human melanoma (HMB45) was from ENZO Diagnostics Inc., New York, USA.
36. B. Lowin, C. Mattman, M. Hahne, J. Tschopp, Int. Immunol. 8, 57 (1996).
37. Frozen sections were stained as in Fig. 2. T cells were detected using the anti-CD3 specific antibody leu-4 (Becton-Dickinson, Oxnard, CA). TUNEL staining was done according to kit instructions from Boehringer, Mannheim, Germany.
38. 5, American Type Tissue Culture) were injected subcutaneously into 4-week old C57BL/6, CSTBL/6-lpr, C57Bl/6-gld (Jackson Laboratory, Bar Harbor, ME), MRL and MRL-lpr mice (Harian, Zeist, Nederland).
39. A. Rensingehl et al., Eur. J. Immunol. 25, 2253 (1995).
40. S. Carrel, M. Schreyer, G. Spagnoli, J.-C. Cerottini, D. Rimoldi, Int. J. Cancer 67, 417 (1996).
41. We thank C. Kamel, F. Beerman, and K. Burns for helpful discussions; S. Hertig and S. Aslan for technical and secretarial assistance; and P. H. Krammer and F. Lejeune for reagents. Supported by grants of the Swiss National Science Foundation (J.T.) and of Human Frontier Science (M.H.). This study is dedicated to Dr. Stephan Carrel (Ludwig Institut of Cancer Research, Lausanne branch). With his death, melanoma research has lost a highly noted authority.